1. Home
  2. ILMN vs BAM Comparison

ILMN vs BAM Comparison

Compare ILMN & BAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • BAM
  • Stock Information
  • Founded
  • ILMN 1998
  • BAM 2022
  • Country
  • ILMN United States
  • BAM Canada
  • Employees
  • ILMN N/A
  • BAM N/A
  • Industry
  • ILMN Medical Specialities
  • BAM
  • Sector
  • ILMN Health Care
  • BAM
  • Exchange
  • ILMN Nasdaq
  • BAM Nasdaq
  • Market Cap
  • ILMN 23.6B
  • BAM 24.7B
  • IPO Year
  • ILMN 2000
  • BAM N/A
  • Fundamental
  • Price
  • ILMN $136.01
  • BAM $54.69
  • Analyst Decision
  • ILMN Buy
  • BAM Buy
  • Analyst Count
  • ILMN 17
  • BAM 13
  • Target Price
  • ILMN $163.12
  • BAM $53.38
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • BAM 727.7K
  • Earning Date
  • ILMN 02-06-2025
  • BAM 02-05-2025
  • Dividend Yield
  • ILMN N/A
  • BAM 2.78%
  • EPS Growth
  • ILMN N/A
  • BAM N/A
  • EPS
  • ILMN N/A
  • BAM 1.09
  • Revenue
  • ILMN $4,390,000,000.00
  • BAM N/A
  • Revenue This Year
  • ILMN N/A
  • BAM N/A
  • Revenue Next Year
  • ILMN $4.05
  • BAM $17.49
  • P/E Ratio
  • ILMN N/A
  • BAM $51.12
  • Revenue Growth
  • ILMN N/A
  • BAM N/A
  • 52 Week Low
  • ILMN $97.36
  • BAM $37.19
  • 52 Week High
  • ILMN $156.66
  • BAM $59.58
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 45.65
  • BAM 44.99
  • Support Level
  • ILMN $130.20
  • BAM $53.85
  • Resistance Level
  • ILMN $135.41
  • BAM $55.56
  • Average True Range (ATR)
  • ILMN 4.45
  • BAM 1.37
  • MACD
  • ILMN -0.50
  • BAM -0.29
  • Stochastic Oscillator
  • ILMN 31.73
  • BAM 31.30

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About BAM Brookfield Asset Management Inc Limited Voting Shares

Brookfield Asset Management Ltd engages in providing alternative asset management services through an ownership interest in a alternative asset management business. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies, and private wealth investors.

Share on Social Networks: